- Home
- Industry Reports
- Packaging
- Pharmaceutical Packaging
- Middle East and Africa Pharmaceutical Contract Manufacturing Market – Size, Outlook, Trends, and Forecast (2024 – 2032)
Contract manufacturing organisation is also known as contract development and manufacturing organisation. It is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. More specifically, contract manufacturing is the outsourcing of certain production activities that were previously performed by the manufacturer to a third-party. Rising need for state-of-the-art processes and production technologies are the factors that boost up the market.
The Middle East and Africa Pharmaceutical Contract Manufacturing Market Segments Size & Growth:
The Middle East and Africa Pharmaceutical Contract Manufacturing Market size are projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. The major factors that propel the growth of the Middle East and Africa Pharmaceutical Contract Manufacturing Market are growing research and development requirements of sourcing companies, increasing awareness about CMOs has led to a rise in research funding, support for clinical and support services and higher number of US FDA-approved manufacturing facilities in emerging countries, increasing aging population and demand for generic drugs and adoption of novel manufacturing technologies. However, without the right packaging, drugs may get damaged in transit or exposed to contaminants that limit their effectiveness, which might hamper the growth of the market.
The Middle East and Africa Pharmaceutical Contract Manufacturing Market Segments Share:
The Middle East and Africa Pharmaceutical Contract Manufacturing Market are segmented by a type which comprises sterile and non-sterile. By product, the market is segmented into finished dosage formulations, active pharmaceutical ingredients, otc medicines and nutritional products, advanced drug delivery products and secondary packaging market. By industry, the market is segmented into pharmaceutical and biopharmaceutical. By technology, the market is segmented into dosage formulation technologies and dosage forms by route of administration. By Geography, the market is segmented into various regions namely the Middle East and Africa.
The Middle East and Africa Pharmaceutical Contract Manufacturing Market Trends:
- Recipharm and Vetcare have announced the signing of an agreement for the development and manufacture of a parenteral veterinary product.
- Catalent, Inc. had announced that it had reached an agreement to acquire Bloomington, an integrated provider of drug substance and drug product manufacturing and related services.
- Aenova group expands its animal health products with a dedicated manufacturing area for solids veterinary pharmaceuticals in Latina (Italy).
The Middle East and Africa Pharmaceutical Contract Manufacturing MarketResearch Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
The Middle East and Africa Diversity are analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players for the Middle East and Africa Pharmaceutical Contract Manufacturing Market are:
- Recipharm AB
- Catalent, Inc.
- Haupt Pharma
- Jubliant life sciences Ltd
- Vetter pharma-fertigung GMBH & CO.KG
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Lower manufacturing costs
4.1.2. Increasing investments in research and development
4.1.3. Increased focus on core competence
4.1.4. Shorter time-to-market
4.2. Restraints
4.2.1. Stringent regulatory requirements
4.2.2. Increasing logistics costs and lead time
4.3. Opportunities
4.3.1. High demand for next-generation biological therapies
4.3.2. Final dosage form manufacturing
4.4. Constraints
4.4.1. Lack of information integration and manufacturing standardization
4.4.2. Lack of in-house laboratory capacity
4.4.3. Increasing complexity of clinical trials
5. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Type
5.1. Introduction
5.2. Sterile
5.3. Non-Sterile
6. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Product
6.1. Introduction
6.2. Finished Dosage Formulations
6.2.1. Solid dose formulation
6.2.2. Liquid dose formulation/Semi-solid formulation
6.2.3. Injectable dose formulation
6.3. Active Pharmaceutical Ingredients
6.4. Otc medicines and nutritional products
6.5. Advanced drug delivery products
6.6. Secondary packaging market
6.7. Others
7. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Industry
7.1. Introduction
7.2. Pharmaceutical
7.3. Biopharmaceutical
8. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Technology
8.1. Dosage formulation technologies
8.1.1. Lipid martiparticulate technology
8.1.2. Abuse-detergent formulation technology
8.1.3. Force control agent technology
8.1.4. Dry powder inhalation technology
8.1.5. Fluidized bed coating technology
8.1.6. Form Eze technology
8.1.7. High-potency drug formulation technology
8.2. Dosage forms by route of administration
8.2.1. Topical
8.2.2. Oral
8.2.3. Rectal
8.2.4. Parenteral
8.2.5. Optic
8.2.6. Vaginal
8.2.7. Inhaled
8.2.8. Ophthalmic
9. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Geography
9.1. Introduction
9.2.Middle East & Africa
9.2.1. Middle East
9.2.2. Africa
10. Middle East and Africa Pharmaceutical Contract Manufacturing Market- Company Profiles
10.1. Recipharm AB
10.2. Catalent, Inc.
10.3. Haupt Pharma
10.4. Jubliant life sciences Ltd
10.5.Vetter pharma-fertigung GMBH & CO.KG
10.6. Aenova
10.7. Pfizer Centresource
10.8. Baxter biopharma solutions
10.9.Famar
11. Middle East and Africa Pharmaceutical Contract Manufacturing Market- Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
13. Appendix
13.1. List of tables
13.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €1,991.88 - €6,639.62
- INR: ₹180,043.09 - ₹600,143.64
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,706.75 - £5,689.16
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Contract manufacturing organisation is also known as contract development and manufacturing organisation. It is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. More specifically, contract manufacturing is the outsourcing of certain production activities that were previously performed by the manufacturer to a third-party. Rising need for state-of-the-art processes and production technologies are the factors that boost up the market.
The Middle East and Africa Pharmaceutical Contract Manufacturing Market Segments Size & Growth:
The Middle East and Africa Pharmaceutical Contract Manufacturing Market size are projected to reach approximately $XX billion by the end of 2024 with a CAGR of close to XX% from $XX billion in 2017 during the forecast timeline 2018-2024. The major factors that propel the growth of the Middle East and Africa Pharmaceutical Contract Manufacturing Market are growing research and development requirements of sourcing companies, increasing awareness about CMOs has led to a rise in research funding, support for clinical and support services and higher number of US FDA-approved manufacturing facilities in emerging countries, increasing aging population and demand for generic drugs and adoption of novel manufacturing technologies. However, without the right packaging, drugs may get damaged in transit or exposed to contaminants that limit their effectiveness, which might hamper the growth of the market.
The Middle East and Africa Pharmaceutical Contract Manufacturing Market Segments Share:
The Middle East and Africa Pharmaceutical Contract Manufacturing Market are segmented by a type which comprises sterile and non-sterile. By product, the market is segmented into finished dosage formulations, active pharmaceutical ingredients, otc medicines and nutritional products, advanced drug delivery products and secondary packaging market. By industry, the market is segmented into pharmaceutical and biopharmaceutical. By technology, the market is segmented into dosage formulation technologies and dosage forms by route of administration. By Geography, the market is segmented into various regions namely the Middle East and Africa.
The Middle East and Africa Pharmaceutical Contract Manufacturing Market Trends:
- Recipharm and Vetcare have announced the signing of an agreement for the development and manufacture of a parenteral veterinary product.
- Catalent, Inc. had announced that it had reached an agreement to acquire Bloomington, an integrated provider of drug substance and drug product manufacturing and related services.
- Aenova group expands its animal health products with a dedicated manufacturing area for solids veterinary pharmaceuticals in Latina (Italy).
The Middle East and Africa Pharmaceutical Contract Manufacturing MarketResearch Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
The Middle East and Africa Diversity are analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
The primary critical players for the Middle East and Africa Pharmaceutical Contract Manufacturing Market are:
- Recipharm AB
- Catalent, Inc.
- Haupt Pharma
- Jubliant life sciences Ltd
- Vetter pharma-fertigung GMBH & CO.KG
1. Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1. Drivers
4.1.1. Lower manufacturing costs
4.1.2. Increasing investments in research and development
4.1.3. Increased focus on core competence
4.1.4. Shorter time-to-market
4.2. Restraints
4.2.1. Stringent regulatory requirements
4.2.2. Increasing logistics costs and lead time
4.3. Opportunities
4.3.1. High demand for next-generation biological therapies
4.3.2. Final dosage form manufacturing
4.4. Constraints
4.4.1. Lack of information integration and manufacturing standardization
4.4.2. Lack of in-house laboratory capacity
4.4.3. Increasing complexity of clinical trials
5. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Type
5.1. Introduction
5.2. Sterile
5.3. Non-Sterile
6. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Product
6.1. Introduction
6.2. Finished Dosage Formulations
6.2.1. Solid dose formulation
6.2.2. Liquid dose formulation/Semi-solid formulation
6.2.3. Injectable dose formulation
6.3. Active Pharmaceutical Ingredients
6.4. Otc medicines and nutritional products
6.5. Advanced drug delivery products
6.6. Secondary packaging market
6.7. Others
7. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Industry
7.1. Introduction
7.2. Pharmaceutical
7.3. Biopharmaceutical
8. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Technology
8.1. Dosage formulation technologies
8.1.1. Lipid martiparticulate technology
8.1.2. Abuse-detergent formulation technology
8.1.3. Force control agent technology
8.1.4. Dry powder inhalation technology
8.1.5. Fluidized bed coating technology
8.1.6. Form Eze technology
8.1.7. High-potency drug formulation technology
8.2. Dosage forms by route of administration
8.2.1. Topical
8.2.2. Oral
8.2.3. Rectal
8.2.4. Parenteral
8.2.5. Optic
8.2.6. Vaginal
8.2.7. Inhaled
8.2.8. Ophthalmic
9. Middle East and Africa Pharmaceutical Contract Manufacturing Market– By Geography
9.1. Introduction
9.2.Middle East & Africa
9.2.1. Middle East
9.2.2. Africa
10. Middle East and Africa Pharmaceutical Contract Manufacturing Market- Company Profiles
10.1. Recipharm AB
10.2. Catalent, Inc.
10.3. Haupt Pharma
10.4. Jubliant life sciences Ltd
10.5.Vetter pharma-fertigung GMBH & CO.KG
10.6. Aenova
10.7. Pfizer Centresource
10.8. Baxter biopharma solutions
10.9.Famar
11. Middle East and Africa Pharmaceutical Contract Manufacturing Market- Competitive Landscape
11.1. Market Share Analysis
11.2. Strategies Adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
12. Market Insights
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
13. Appendix
13.1. List of tables
13.2. List of figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.